Skip to content

Feasibility of a Virtual Smoking Cessation Program

Smoking Cessation | Smoking | Fractures, Bone | Perioperative/Postoperative Complications | Smoking Reduction

The goal of this pilot study of a clinical trial is to learn about the acceptability and feasibility of a virtual smoking cessation program in both the perioperative and fracture clinic settings. The main questions this study aims to answer are:

* The number of people that participate in the virtual smoking cessation program
* The acceptability of the number, length, content, and delivery of the email messages provided by the program.

Participants will be asked to subscribe to our virtual intervention which will include:

* A smoking cessation e-learning module component to provide education on the risks of smoking in the surgical or fracture clinic setting, and
* An emailing program component that will provide tailored email messages over a 30-45 day period depending on a patient's Fagerstrom test for nicotine dependence score and motivation to quit smoking.

Researchers will also compare the virtual smoking cessation program to standard care to see if there are any differences shown between both groups in the Fagerstrom test for nicotine dependence scores, number of cigarettes smoked, number of quit attempts, complication rates, and re-admission rates at the 7 day and 30 day time points.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* 18+ years of age
* Daily or non-daily smoker
* Self-reported smokers who have smoked cigarettes within the past 30 days
* Must be a patient at Toronto Western Hospital or Women's College Hospital who is:

* Scheduled for an elective surgical procedure that will occur at least 48 hours after recruitment OR
* Visiting the fracture clinic (UHN) within and including 14 days from the initial date of injury or operation
* Must have a working e-mail address

Exclusion Criteria:

* Patients who have already quit smoking for more than 30 days,
* Patients who cannot read and understand English,
* Patients who have any form of cognitive impairment,
* Patients who do not have a telephone (for follow-up).
* Currently on pharmacological therapy for smoking cessation
* Drug or alcohol abuse or dependence within the past year

Study Location

Women's College Hospital
Women's College Hospital
Toronto, Ontario
Canada

Contact Study Team

Backup Contact

Didem Bozak

(416)-323-6008
Primary Contact

Rachel Ortiz

[email protected]
4163236400
Study Sponsored By
University Health Network, Toronto
Participants Required
More Information
Study ID: NCT05594199